Madhav V. Dhodapkar

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Madhav V. Dhodapkar

Sep 22, 2024, 13:33 | Insight

Ajay Nooka: This paper by Nisha S Joseph is not only practice changing manuscript but a very important milestone

Vincent Rajkumar shared a post by Ajay Nooka, Professor Dept. Hematology/Oncology at Emory School of Medicine, on…

Jun 23, 2024, 19:16 | Insight

Joshua Richter: Amazing Paper on Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology at The Tisch Cancer Institute,…

Jun 21, 2024, 14:36 | Insight

High ORR and low CRS rate with Linvoseltamab for R/R Multiple Myeloma

Recently Jeffrey Zonder shared a post on X about a recent paper by Naresh Bumma…

Jun 17, 2024, 14:25 | Insight

Myeloma Paper of the Day, June 17th, suggested by Robert Orlowski

Robert Orlowski shared on X: “Myeloma Paper of the Day: Linvoseltamab BCMA TCE (B-cell maturation antigen,…

All: 4 Posts: 1 - 100

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023